Company: OSRH
Filing Date: 2025-01-10
Form Type: 8-K
Source: 0001193125-25-004439
Chunk: 0

Company: OSR Holdings, Inc.
Filing Date: 2025-01-10
Form: 8-K
Item: Item 2.03
Chunk 0
---
Item 2.03.      Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.  

Promissory Note Amendments

As previously disclosed by Bellevue Life Sciences Acquisition Corp. (the “ Company”) in its Current Reports on Form8-Kfiled with the Securities and Exchange Commission on (i) April 11, 2024, (ii) April 22, 2024, (iii) May 14, 2024, and (iv) July 16, 2024, the Company issued unsecured promissory notes (each, a “ Promissory Note” and, collectively, the “ Promissory Notes”) to Bellevue Global Life Sciences Investors, LLC, the Company’s sponsor (“ Sponsor”), on (i) April 8, 2024, (ii) April 17, 2024, (iii) May 14, 2024, and (iv) July 11, 2024, in the principal amounts of (i) $1,200,000, (ii) $50,000, (iii) $140,000, and (iv) $300,000, respectively.